|
Drug
|
Idiopathic Uveitis
|
JIA Uveitis
|
|---|
|
N = 92 (%)
|
N = 643 (%)
|
|---|
|
Methotrexate
|
70 (76)
|
549 (85)
|
|
Oral
|
44 (48)
|
375 (58)
|
|
SQ
|
46 (50)
|
416 (65)
|
|
Mycophenolate mofetil
|
9 (10)
|
33 (5)
|
|
Cyclosporine
|
3 (3)
|
20 (3)
|
|
Sulfasalazine
|
1 (1)
|
47 (7)
|
|
Hydroxychloroquine
|
0 (0)
|
27 (4)
|
|
Leflunomide
|
0 (0)
|
20 (3)
|
|
Tacrolimus
|
0 (0)
|
8 (1)
|
|
Azathioprine
|
0 (0)
|
3 (0.4)
|
|
Cyclophosphamide
|
0 (0)
|
1 (0.2)
|
- Data in this table represent “ever drug use” in patients with data available on DMARD drug exposure (92/92 patients with idiopathic uveitis and 643/646 patients with JIA uveitis)
-
JIA juvenile idiopathic arthritis, SQ subcutaneous
